Clinical Trial Update: The Effect of Modified Sham Feeding With Orlistat in Overweight and Obese Subjects [NA]

View source ↗

Summary

A clinical trial investigating modified sham feeding with orlistat in overweight and obese subjects has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Orlistat (orlistat)

Snippet

Sponsor: Pennington Biomedical Research Center | Conditions: Overweight | NA | Status: WITHDRAWN